Hanrui Zheng Selected Research

Hanrui Zheng Research Topics

4	Neoplasms (Cancer) 01/2022 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 04/2020
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 11/2016
2	Adenocarcinoma 01/2020 - 11/2016
1	Disease Progression 01/2022
1	Diabetic Foot 01/2022
1	Ulcer 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Diabetes Mellitus 01/2022
1	Esophageal Neoplasms (Esophageal Cancer) 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Overweight 01/2021
1	Obesity 01/2021
1	Infections 01/2021
1	Nasopharyngeal Carcinoma 02/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Esophageal Squamous Cell Carcinoma 12/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 12/2018
1	Adenocarcinoma of Lung 12/2018
1	Ovarian Neoplasms (Ovarian Cancer) 12/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Malignant Mesothelioma 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2015

3	Cisplatin (Platino)FDA LinkGeneric 02/2020 - 11/2016
3	Fluorouracil (Carac)FDA LinkGeneric 02/2020 - 11/2016
2	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2017
2	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 04/2020
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 11/2016
2	Leucovorin (Folinic Acid)FDA Link 01/2020 - 11/2016
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	pembrolizumabIBA 01/2022
1	LigandsIBA 01/2022
1	avelumabIBA 01/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021
1	SodiumIBA 01/2021
1	theasinensin AIBA 01/2021
1	atezolizumabIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Fetal Proteins (Fetoprotein)IBA 04/2020
1	RamucirumabIBA 04/2020
1	Gemcitabine FDA Link 02/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	olaparibIBA 01/2020
1	Pharmaceutical PreparationsIBA 12/2018
1	mangiferinIBA 12/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Growth Factor ReceptorsIBA 01/2018
1	Pemetrexed (MTA)FDA Link 01/2017
1	Capecitabine (Xeloda)FDA Link 11/2016
1	Epirubicin (Ellence)FDA LinkGeneric 11/2016
1	Cetuximab (Erbitux)FDA Link 01/2015
1	Monoclonal AntibodiesIBA 01/2015

6	Therapeutics 01/2022 - 01/2015
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
1	Glycemic Control 01/2021
1	Neoadjuvant Therapy 12/2019
1	Transplantation 01/2019
1	Liver Transplantation 01/2019
1	Islets of Langerhans Transplantation 01/2019
1	Radiotherapy 12/2018